Clinical Trials Browser

Phase 2 × Electroporation Therapies × 90 days × Clear all

NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Phase 2 Completed

44 enrolled 15 charts

Squamous Intraepithelial Lesions, HIV Seropositivity